APP and Alzheimer disease: These findings suggest that XTS exerts its anti-AD effects by modulating the abundance and function of gut microbiota in APP/PS1 mice, enhancing carbohydrate metabolism and the biosynthesis of secondary metabolites, and downregulating xenobiotics biodegradation and metabolism.